Pediatric ID

Adult ID

Epi/Infection Control

Trainee

Symposium

284 - Antivirals and Use of PCR Testing for Respiratory Viruses

Co-organized with the Centers for Disease Control and Prevention

Learning Objectives:

At the conclusion of this session, participants will be able to:

• explain how laboratory testing for respiratory viruses can impact antibiotic usage
• list antivirals for respiratory viruses
• discuss current approaches to laboratory testing for respiratory virus vaccines

Presentations:

• 1:45 PM - 2:10 PM

  2810 - Updates on Antivirals-Not Just Influenza
  Flor M. Munoz, MD – Baylor College of Medicine
• 2:10 PM - 2:35 PM

  2811 - Current Approaches to Laboratory Testing for Respiratory Viruses
  Richard L. Hodinka, PhD – University of South Carolina
• 2:35 PM - 3:00 PM

  2812 - Respiratory Virus PCR Testing and Antibiotic Use: Potential for Impact
  Evan J. Anderson, MD – Emory University, Atlanta VA Medical Center

Moderator(s)

• 

  Inger Damon, MD, PhD

  Director Division of High Consequence Pathogens and Pathology
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: Nothing to disclose
• 

  Susan Gerber, MD

  Chief, Respiratory Viruses Branch, Division of Viral Diseases
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose

Speaker(s)

• EA

  Evan Anderson, MD

  Infectious Diseases Physician
  Emory University, Atlanta VA Medical Center
  Atlanta, Georgia
• 

  Richard Hodinka, PhD

  Professor, Microbiology; Chair, Department of Biomedical Sciences
  University of South Carolina
  Greenville, SC

  Disclosure: Nothing to disclose
• 

  Flor Munoz, MD

  Associate Professor of Pediatrics
  Baylor College of Medicine
  Houston, TX

  Disclosure: Biocryst: Grant/Research Support
  CDC: Research Grant
  Moderna: Other Financial or Material Support, Safety Monitoring Board Member/Chair
  NIH: Research Grant
  Novavax: Research Grant
  UP to Date: Author and Editor - Royalties, Other Financial or Material Support